Lung Cancer Clinical Trial

Clinical Trial Finder Lung Cancer Trials

Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma

See Locations Near You

Summary

Open label study of sorafenib

View Full Description

Full Description

Open label study using oral sorafenib 800 mg daily in any stage III-IV BAC lung cancer and Stage III-IV adenocarcinoma of the lung in nonsmokers (less than < 100 cigarettes lifetime).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age > 18
Life expectancy > 12 weeks
Biopsy-proven BAC or adenocarcinoma
Willing to provide smoking status
Selected IIIB or stage IV cancer that is incompletely resected or unresectable

Exclusion Criteria:

O2 saturation < 88% on room air
Pregnant or nursing women
Surgery or radiation therapy within 4 weeks of starting study
Major heart condition within 6 months of starting therapy
Certain concomitant medications prohibited

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

5

Study ID:

NCT00456716

Recruitment Status:

Completed

Sponsor:

Swedish Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Swedish Cancer Institute
Seattle Washington, 98104, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

5

Study ID:

NCT00456716

Recruitment Status:

Completed

Sponsor:


Swedish Medical Center

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
When Should I Consider Clinical Trials?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider